Bringing Innovation and Excellence to Clinical Trials Since 1996At Clinical Research Philadelphia (CRP), we are dedicated to advancing healthcare through high-quality clinical research. With over 25 years of experience and more than 400 completed trials, we have established ourselves as a trusted partner in the clinical research community. Our expertise spans multiple therapeutic areas, supported by a research team with over 90 years of combined experience.Our Core Strengths:Diversity and Patient-Centricity: We are proud of our diverse staff and participant base, fostering inclusivity in every aspect of our work. Our patient-centric approach ensures that we provide exceptional clinical experiences, consistently exceeding the expectations of our sponsors and partners.Advanced Technology: We leverage cutting-edge technology, including a fully electronic Clinical Trial Management System (CTMS) with remote monitoring capabilities, to streamline operations and ensure data accuracy and compliance.Robust Partnerships: Our extensive network includes over 60 community-based providers, granting us EMR-level access to more than 600,000 patient charts. This enables comprehensive, real-time, HIPAA-compliant patient data mining, allowing us to identify and recruit the most suitable candidates for clinical trials.State-of-the-Art Facility: Located in the heart of Philadelphia, our 4,000 sq. ft. dedicated research facility is equipped with modern medical equipment and is designed to provide a comfortable and professional environment for every study participant.

Account lead responsible for multiple projects and managing a team of 5 consultants and 2 associatesGrew account by over 300% over 12 months, representing $1.5M in new projects Developed go-to-market strategy for a $2 billion franchise introducing a novel product for a nascent market Supported product lifecycle initiatives for Psychiatry brand by mapping the customer journey, defining market segmentation, and forecasting market share for various scenarios

Created launch excellence framework for multiple biopharmaceutical organizations by developing cross-functional launch plans, governance protocols, leadership dashboards and risk mitigation plans across multiple therapeutic areas including Oncology, Psychiatry, Hemophilia, Diabetes and Respiratory Developed strategic plan for in-line product, including market landscape, strategic map and tactical plan in alignment with corporate strategic imperativesSupported employer pull-through market access strategy for an in-line obesity brand including conventions planning, employer segmentation and patient access programsDeveloped copay modeling for Diabetes launch brand to optimize buy-down and recommended strategy based on comparison with analogs and internal dataCoordinated and directed all agency and vendor activities including long-range tactical and budget planning and project tracking for multiple clients

Led hematology global strategic marketing team in developing a comprehensive global sales training program for the launch of a new recombinant treatment for Hemophilia AConducted robust analysis of internal and external brands and recommended a new salestraining model, which incorporated the strategic objectives of the global brand plan andwas adaptable to fit the needs of 70+ countriesGained buy-in from senior management to implement sales training program, then collaborated withexternal agencies and Medical Affairs to drive creation of six commercial and scientific learningmodules and two distance learning interactive Webinars to train global salesforce (60+)

Initiated and maintained collaborative relationships with clinical investigators across 45 sites toensure compliance of clinical trials with Good Clinical PracticesLed and represented the clinical team in global cross-functional projects ensuring the effectivedelivery of assigned project milestonesIdentified risks to patient recruitment and formulated solutions by eliciting feedback fromparticipating clinicians during an international conferencePart of the team that received 2013 Novo Nordisk President’s Award for executing startup ofdecisive clinical trial, reaching target enrollment four months ahead of schedule, and resulting insubstantial earnings potential

Executed study startup for all clinical trials by identifying clinical team needs and providingdirection and oversight to vendorsEvaluated potential vendors by analyzing their capabilities and track record to exceed performancemeasures, and selected vendor that was approved by senior managementAnalyzed study metrics to communicate leading/lagging indicators to Study Director in accordancewith the project plan

Managed portfolio of over 40 clinical trials in thoracic oncology by facilitating communicationbetween 10 oncologists and 15 pharmaceutical sponsorsSupervised staff of 11 research study assistants with responsibility of setting and tracking goals,training, growth progress, performance appraisals, and career developmentReduced project approval 30% utilizing six-sigma principles and designing dashboard thatdisplayed the real-time status of all clinical trialsAuthored whitepaper on initiative between Novartis and MSKCC to utilize new technology

Managed imaging operations for 25+ global clinical trials, including three pivotal studies pending FDA approval Decreased turnaround time of service and deliverables 40% by integrating business functions of 120 employees Liaised between six pharmaceutical sponsors and 100+ site staff to ensure that clinical trial deliverables were met

Acted as the primary liaison for the sponsor and sites staff and lead sponsor teleconferences to convey study progress Mentored new team members and provided annual performance appraisals. Delegated assignments to project coordinators and tracked overall study progress.

Executed technical and clinical functions of the study in accordance to the protocol. Analyzed Patient Status Reports to identify any adverse issues and convey them to the sponsor.

Developed an Independent research project to study the effects of phosphorylated proteins in immortalized pituitary cell linesAnalyzed results by developing assays, using western blots and x-ray autoradiographyTrained on specific mRNA quantification, cryosectioning and qRT-PCR

Formulated and executed an independent project to reduce the post-operation length of stay of patientsAnalyzed trends in hospital performance to streamline post-procedure patient care